World & BusinessWeight-loss pills’ projected share of the global obesity drug market by 2030
Reuters reports that Novo Nordisk’s CEO says pills could capture as much as half of the global obesity drug market by 2030.
TLDR
Novo Nordisk is positioning itself for a shift away from weekly injections, Reuters reports. Its chief executive told the news agency that weight-loss pills could capture as much as half of the global obesity drug market by 2030.
Weight-loss pills’ projected share of the global obesity drug market by 2030
Reuters reports that Novo Nordisk’s CEO says pills could capture as much as half of the global obesity drug market by 2030.
TLDR
Novo Nordisk is positioning itself for a shift away from weekly injections, Reuters reports. Its chief executive told the news agency that weight-loss pills could capture as much as half of the global obesity drug market by 2030.